Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > February & end of 90 day exclusivity.
View:
Post by fox7mf on Jan 24, 2023 5:56am

February & end of 90 day exclusivity.

We're just a handful of trading days away from the end of PFE's right of first refusal on Bracelet & mBC. The corporate presentation was missing for days just for minor language changes, perhaps to weigh the presentation more towards commercial development, FDA approvals and attracting a larger investor base. I'm of the opinion that the cleanup is in preparation for final negotiations, to cover all angles, as we wait for word on a PFE offer, which I'm sure is coming in short order. A poster on Stocktwits suggested selling/licensing Pela/ mBC to PFE for $5b, and doing the same for Roche and Pela/pancreatic. Not likely, but compelling. 
Comment by Lesalpes29 on Jan 24, 2023 6:29am
For sure they had a good reason to shut down the presentation during the change of it. Time for news now I hoe. Everything seems to be in place. 
Comment by Lesalpes29 on Jan 24, 2023 10:43am
When we see a flash drop like that I always asking myself... did I miss something. Investing is nit easy! GL
Comment by Noteable on Jan 24, 2023 11:30am
The 90 day exclusivity period ends sometime by the middle to the end of February. That equates to 3-5 weeks.from now.
Comment by canadafan on Jan 24, 2023 12:14pm
Regarding the 90 day exclusivity. I agree, as the dates line up. regarding the investor presentation change. mostly legal word smithing. most unusual they changed from " strong" to " robust". look them up. Difference is very subtle. taking down the cash run rate? that number does change, monthly based on ATM usage, operating costs etc. could mean something or nothing. maybe ...more  
Comment by fox7mf on Jan 24, 2023 12:19pm
Hey Note...are you positive it's that far away? I figured first week of February, but you have a greater handle on these matters. 
Comment by westcoast1000 on Jan 24, 2023 12:28pm
fox, It is not easy to precisely determine when the period started. It is roughly in the neighborhood being suggested on here but no one outside the companies involved knows precisely. 
Comment by Lesalpes29 on Jan 24, 2023 1:28pm
Before the end of the 90 days we will see a big SP jump!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities